Do you account for dose from previous Lu-177 treatment for definitive prostate cancer treatment?  

Per lutathera information, a patient who had previous treatment for describes an estimated radiation absorbed dose of 12.8 Gy to the bladder. Would you change your dose constraints to the bladder based on this information?

Answer from: Radiation Oncologist at Academic Institution